Table 2.

Most common (> 10%) treatment-emergent adverse events.

Adverse EventVLD CBP (N = 18), n (%)Placebo (N = 18), n (%)
Any adverse event15 (83)15 (83)
Headache7 (39)3 (17)
Dry mouth6 (33)1 (6)
Somnolence4 (22)2 (11)
Constipation3 (17)1 (6)
Dizziness3 (17)1 (6)
Nausea2 (11)5 (28)
Flu syndrome2 (11)1 (6)
Rhinitis2 (11)1 (6)
Pruritus2 (11)0